基本信息
文件名称:PLK1-IN-14-生命科学试剂-MCE.pdf
文件大小:459.54 KB
总页数:1 页
更新时间:2025-05-21
总字数:约1.92千字
文档摘要

Hotline:400-820-3792

Inhibitors?ScreeningLibraries?Proteins

www.MedChemE

PLK1-IN-14

Cat.No.:HY-173233

分?式:C??H??F?N?O?

分?量:802.92

作?靶点:Polo-likeKinase(PLK)

作?通路:CellCycle/DNADamage

储存?式:Pleasestoretheproductundertherecommendedconditionsin

theCertificateofAnalysis.

BIOLOGICALACTIVITY

?物活性PLK1-IN-14(CompoundHit-4)是?种选择性PLK1抑制剂,对PLK1的IC50为22.61pM,对DU-145前列腺

癌细胞增殖的IC50为0.09nM。PLK1-IN-14可?于前列腺癌的研究[1]。

IC50TargetPLK1

22.61pM(IC50)

REFERENCES

[1].XuZ,etal.DiscoveryofanovelPLK1inhibitorwithhighinhibitorypotencyusingacombinedvirtualscreeningstrategy.JEnzymeInhib

MedChem.2025Dec;40(1):2467798.

McePdfHeight

Caution:Producthasnotbeenfullyvalidatedformedicalapplications.

Forresearchuseonly.

Tel:400-820-3792;021Fax:021E-mail:tech@MedChemE

1/1MasterofBioactiveMolecules—您?边的抑制剂?师